Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Rx.com Tirzepatide Review: $285 a Month, and the $146 Is a Different Drug (2026)

Rx.com charges $285 a month for compounded tirzepatide, flat at every dose. The $146 in its headline is a six-month semaglutide prepay — here is the real bill.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Breeze Meds

LegitScript-certified compounded tirzepatide from $299, with nothing charged until a provider approves you.

$399/mo ($299 first month)

Check Breeze Meds availability

Rx.com sells compounded tirzepatide at $285 a month, month to month, the same price whether your provider has you at 2.5 mg or 15 mg. Prepay and it falls to $265 a month on three months ($795) or $259 on six ($1,550). The number the company actually advertises — $146 a month, "FOR LIFE" — is neither of those: it is a six-month prepay on semaglutide, a different drug.1 Every figure here was read on the company's own weight-loss page on 13 September 2026.

§ Rx.com — what each plan costs, read 13 September 2026

Plan lengthTirzepatideSemaglutide
1 month (month to month)$285$175
3 months, paid up front$265/mo ($795)$165/mo ($495)
6 months, paid up front$259/mo ($1,550)$146/mo ($875)
The $146 the company advertises is the bottom-right cell — a six-month prepay on the other drug. Month-to-month tirzepatide is $285.

Three things most programs we review leave out

It prints "No automatic renewals" under the tirzepatide plan card itself. Not in the terms, not in a FAQ — on the card, beside the price. In a category built on subscriptions that quietly re-bill, that is the single most unusual sentence on the page.

It names the pharmacy that dispenses the drug, with a street address. The plan page says medications are dispensed by Manifest Pharmacy at 1018 S. Batesville Road, Greer, SC 29650, and names MD Integrations as the provider network. Most sellers in this field say "a licensed U.S. compounding pharmacy" and stop, or — like Science & Co — say only what they are not.

It says a provider decides, and that a no is free. If a clinician declines to prescribe, the card says you are not charged for medication.

The headline, and what it is actually selling

A sticky banner rides every page reading "EXCLUSIVE LIFETIME OFFER · COUPON AUTO-APPLIED · $146/mo FOR LIFE", with "*on a 6-month plan" set beside it in smaller type, and the hero repeats "From $146 a month". Two separate things are compressed into that number. It is a prepay rate, not a monthly one — and it is the semaglutide rate. Month-to-month tirzepatide is $285, which is 95% higher. "FOR LIFE" is describing a six-month commitment.

The coverage claim contradicts itself

The banner says "Licensed Providers in all 50 States". The plan page, further down the same site, says "49 states served". Both cannot be right, and the company does not say which state is the exception or which figure is current. If you live somewhere that might be the forty-ninth, the intake is the only place you will find out.

What the price includes

The provider visit, injection supplies and cold shipping are all stated as included, with the page adding "No membership fee, no separate medication bill, no dose upcharge." That is a genuinely all-in figure, and it is why the $285 compares honestly against programs that quote a lower drug price and bill a membership beside it — see our Eden review for the other shape.

The brand-vs-compounded question

This is compounded tirzepatide, not Zepbound or Mounjaro. Compounding happens at a pharmacy, produces no FDA-approved finished product, and puts the vial outside what the pivotal trials measured. Our guide to whether compounded tirzepatide is still legal in 2026 covers where that stands.

Does the drug work? (Separate from the provider)

Pricing is the seller's problem; efficacy is the molecule's, and tirzepatide's record is strong. SURMOUNT-1 put weight loss at roughly 15% to 21% of body weight over 72 weeks2, and SURMOUNT-5 placed it ahead of semaglutide head to head3, both on the approved brand product. Our tirzepatide evidence guide has the full picture.

The honest verdict

Judge Rx.com on its plan card rather than its banner and it is one of the better-disclosed programs on this list: a named dispensing pharmacy with an address, no automatic renewals, one flat price at every dose, and no charge if a provider says no. Judge it on the banner and it is selling you a different drug at a different term. Read past the $146 and decide on the $285. If you want the same flat-at-every-dose promise with the headline already telling the truth, Renlo Health publishes its real month-to-month rate; if you want the fullest published price table in this field, No BS RX prints six programs across four terms on one page. The ranked best tirzepatide providers list sets all three against the field.

Frequently asked questions

How much does tirzepatide cost at Rx.com?

$285 a month month-to-month, falling to $265 a month on a three-month prepay and $259 on six. The price is the same at every dose from 2.5 mg to 15 mg.

Is the $146 in Rx.com's advertising the tirzepatide price?

No. $146 is the six-month prepay rate for compounded semaglutide, a different drug. The tirzepatide equivalent is $259, and month-to-month tirzepatide is $285.

Does Rx.com say which pharmacy dispenses the medication?

Yes — the plan page names Manifest Pharmacy in Greer, South Carolina, with a street address, and names MD Integrations as the provider network.

References(3)

  1. Rx.com, operated by Rx Platform LLC (2026). GLP-1 weight loss plan cards, pricing ladder, dispensing-pharmacy disclosure and coverage claims. rx.com. https://rx.com/weightloss
  2. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  3. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated September 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.